Opportunity ID: 333654

General Information

Document Type: Grants Notice
Funding Opportunity Number: W81XWH-21-RCRP-IDA
Funding Opportunity Title: DOD Rare Cancers Idea Development Award
Opportunity Category: Discretionary
Opportunity Category Explanation:
Funding Instrument Type: Cooperative Agreement
Grant
Category of Funding Activity: Science and Technology and other Research and Development
Category Explanation:
Expected Number of Awards: 15
Assistance Listings: 12.420 — Military Medical Research and Development
Cost Sharing or Matching Requirement: No
Version: Synopsis 2
Posted Date: May 18, 2021
Last Updated Date: May 28, 2021
Original Closing Date for Applications: Oct 15, 2021
Current Closing Date for Applications: Oct 15, 2021
Archive Date: Nov 14, 2021
Estimated Total Program Funding: $8,400,000
Award Ceiling:
Award Floor:

Eligibility

Eligible Applicants: Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled “Additional Information on Eligibility”
Additional Information on Eligibility:

Additional Information

Agency Name: Dept. of the Army — USAMRAA
Description:

The FY21 RCRP Idea Development Award mechanism promotes new ideas that are still in the early stages of development and have the potential to yield impactful data and new avenues of investigation. This award supports conceptually innovative, high-risk/high-reward research that could lead to critical discoveries or major advancements that will accelerate progress toward eradicating deaths and suffering from rare cancers. Applications should include a well-formulated, testable hypothesis based on strong scientific rationale.

Preliminary data with disease-specific rationale (may include correlatives in existing trials) to support the feasibility of the research hypotheses and research approaches are required; however, these data do not necessarily need to be derived from studies of the proposed rare cancer type(s)/subtype(s) under study.

Link to Additional Information:
Grantor Contact Information: If you have difficulty accessing the full announcement electronically, please contact:

CDMRP Help Desk

Phone: 301-682-5507

Email: help@eBRAP.org
Email:help@eBRAP.org

Version History

Version Modification Description Updated Date
The package has been updated to replace the original UEI package with DUNs package. May 28, 2021
May 18, 2021

DISPLAYING: Synopsis 2

General Information

Document Type: Grants Notice
Funding Opportunity Number: W81XWH-21-RCRP-IDA
Funding Opportunity Title: DOD Rare Cancers Idea Development Award
Opportunity Category: Discretionary
Opportunity Category Explanation:
Funding Instrument Type: Cooperative Agreement
Grant
Category of Funding Activity: Science and Technology and other Research and Development
Category Explanation:
Expected Number of Awards: 15
Assistance Listings: 12.420 — Military Medical Research and Development
Cost Sharing or Matching Requirement: No
Version: Synopsis 2
Posted Date: May 18, 2021
Last Updated Date: May 28, 2021
Original Closing Date for Applications: Oct 15, 2021
Current Closing Date for Applications: Oct 15, 2021
Archive Date: Nov 14, 2021
Estimated Total Program Funding: $8,400,000
Award Ceiling:
Award Floor:

Eligibility

Eligible Applicants: Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled “Additional Information on Eligibility”
Additional Information on Eligibility:

Additional Information

Agency Name: Dept. of the Army — USAMRAA
Description:

The FY21 RCRP Idea Development Award mechanism promotes new ideas that are still in the early stages of development and have the potential to yield impactful data and new avenues of investigation. This award supports conceptually innovative, high-risk/high-reward research that could lead to critical discoveries or major advancements that will accelerate progress toward eradicating deaths and suffering from rare cancers. Applications should include a well-formulated, testable hypothesis based on strong scientific rationale.

Preliminary data with disease-specific rationale (may include correlatives in existing trials) to support the feasibility of the research hypotheses and research approaches are required; however, these data do not necessarily need to be derived from studies of the proposed rare cancer type(s)/subtype(s) under study.

Link to Additional Information:
Grantor Contact Information: If you have difficulty accessing the full announcement electronically, please contact:

CDMRP Help Desk

Phone: 301-682-5507

Email: help@eBRAP.org
Email:help@eBRAP.org

DISPLAYING: Synopsis 1

General Information

Document Type: Grants Notice
Funding Opportunity Number: W81XWH-21-RCRP-IDA
Funding Opportunity Title: DOD Rare Cancers Idea Development Award
Opportunity Category: Discretionary
Opportunity Category Explanation:
Funding Instrument Type: Cooperative Agreement
Grant
Category of Funding Activity: Science and Technology and other Research and Development
Category Explanation:
Expected Number of Awards: 15
Assistance Listings: 12.420 — Military Medical Research and Development
Cost Sharing or Matching Requirement: No
Version: Synopsis 1
Posted Date: May 18, 2021
Last Updated Date: May 18, 2021
Original Closing Date for Applications:
Current Closing Date for Applications: Oct 15, 2021
Archive Date: Nov 14, 2021
Estimated Total Program Funding: $8,400,000
Award Ceiling:
Award Floor:

Eligibility

Eligible Applicants: Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled “Additional Information on Eligibility”
Additional Information on Eligibility:

Additional Information

Agency Name: Dept. of the Army — USAMRAA
Description:

The FY21 RCRP Idea Development Award mechanism promotes new ideas that are still in the early stages of development and have the potential to yield impactful data and new avenues of investigation. This award supports conceptually innovative, high-risk/high-reward research that could lead to critical discoveries or major advancements that will accelerate progress toward eradicating deaths and suffering from rare cancers. Applications should include a well-formulated, testable hypothesis based on strong scientific rationale.

Preliminary data with disease-specific rationale (may include correlatives in existing trials) to support the feasibility of the research hypotheses and research approaches are required; however, these data do not necessarily need to be derived from studies of the proposed rare cancer type(s)/subtype(s) under study.

Link to Additional Information:
Grantor Contact Information: If you have difficulty accessing the full announcement electronically, please contact:

CDMRP Help Desk

Phone: 301-682-5507

Email: help@eBRAP.org
Email:help@eBRAP.org

Folder 333654 Full Announcement-FY21 RCRP IDA -> RCRP-FY21_IDA_PA_GG.pdf

Packages

Agency Contact Information: CDMRP Help Desk
Phone: 301-682-5507
Email: help@eBRAP.org
Email: help@eBRAP.org
Who Can Apply: Organization Applicants

Assistance Listing Number Competition ID Competition Title Opportunity Package ID Opening Date Closing Date Actions
12.420 PKG00267408 May 18, 2021 Oct 15, 2021 View

Package 1

Mandatory forms

333654 RR_SF424_3_0-3.0.pdf

333654 AttachmentForm_1_2-1.2.pdf

333654 RR_PersonalData_1_2-1.2.pdf

333654 RR_KeyPersonExpanded_3_0-3.0.pdf

333654 RR_Budget_1_4-1.4.pdf

333654 PerformanceSite_3_0-3.0.pdf

Optional forms

333654 RR_SubawardBudget30_1_4-1.4.pdf

2025-07-11T09:10:13-05:00

Share This Post, Choose Your Platform!

About the Author: